Shemesh, Colby S.
Wang, Yongsheng
An, Andrew
Ding, Hao
Chan, Phyllis
Liu, Qi
Chen, Yih-Wen
Wu, Benjamin
Wu, Qiong
Wang, Xian
Funding for this research was provided by:
F. Hoffmann-La Roche Ltd
Article History
Received: 21 December 2023
Accepted: 5 February 2024
First Online: 7 March 2024
Declarations
:
: C.S.S., H.D., P.C., Q.L., Y.C., and B.W. are employees of Genentech, Inc., and F. Hoffman La-Roche Ltd. stockholders. A.A. and Q.W. are employees of F. Hoffmann-La Roche Ltd. and F. Hoffman La-Roche Ltd, stockholders.
: This study was performed in full conformance with the ICH E6 guideline for Good Clinical Practice and in line with the principles of the Declaration of Helsinki, or the applicable laws and regulations of the country in which the research was conducted, whichever afforded the greater protection to the individual. The study protocol and protocol amendments were approved by the institutional review board or ethics committee.
: All patients enrolled in the YP42514 study provided written informed consent to participate. No identifying information for individual patients is included in this article.
: Since all data are anonymized before publication, no additional consents were obtained.